Escitalopram co-prescription in anastrozole-treated breast cancer patients

OBJECTIVE: The purpose of the study was to evaluate the impact of escitalopram co-prescription on plasma anastrozole levels in post-menopausal breast cancer patients. METHODS: A total of 24 post-menopausal operated breast cancer patients co-prescribed with escitalopram and anastrozole were included....

Descripción completa

Detalles Bibliográficos
Autores principales: Ozyurt, Hazan, Ozden, Sevgi, Gemici, Cengiz, Kucukibrahimoglu, Esra, Odabas, Hatice, Nesetoglu, Neset, Unal, Durisehvar, Uler, Pinar, Yaprak, Gokhan, Tepetam, Huseyin, Gumus, Mahmut, Goren, Mehmet Zafer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464843/
https://www.ncbi.nlm.nih.gov/pubmed/36199859
http://dx.doi.org/10.14744/nci.2022.48264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464843/
https://www.ncbi.nlm.nih.gov/pubmed/36199859
http://dx.doi.org/10.14744/nci.2022.48264

Ejemplares similares